Oseltamivir Phosphate Capsule shortage

To Be Discontinued

Oseltamivir Phosphate Capsule is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.

Therapeutic category

Antiviral

Dosage form

Capsule

Routes

ORAL

Last updated

09/30/2025

Strength variants

Not specified

Need sourcing help for Oseltamivir Phosphate Capsule?

Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.

Connect with a sourcing partner

Manufacturers reporting shortage

Genentech, Inc800-551-2231
To Be Discontinued
Genentech, Inc800-551-2231
To Be Discontinued

Reason for shortage

Not specified

ad slot 300x250

Related shortages in Antiviral

Peginterferon alfa-2a Injection

Currently in Shortage

Category: Antiviral
Reason: Shortage of an active ingredient
Updated: 08/19/2025

Peginterferon alfa-2a Injection

Currently in Shortage

Category: Antiviral
Reason: Shortage of an active ingredient
Updated: 08/19/2025

This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.